MDMB-5Br-INACA

MDMB-5Br-INACA_structure.png

MDMB-5Br-INACA is a synthetic cannabinoid that has been identified in various designer drug products. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body.

Chemical Structure and Properties

MDMB-5Br-INACA belongs to the class of indazole-3-carboxamide derivatives. Its chemical structure includes a bromine atom, which distinguishes it from other synthetic cannabinoids. The full chemical name is Methyl 2-[[1-(5-bromopentyl)-1H-indazole-3-carbonyl]amino]-3-methylbutanoate.

Pharmacology

As a synthetic cannabinoid, MDMB-5Br-INACA acts on the CB1 and CB2 receptors in the central nervous system and peripheral nervous system. These receptors are involved in various physiological processes, including pain sensation, mood, and appetite.

Legal Status

The legal status of MDMB-5Br-INACA varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. It is often included in legislation targeting new psychoactive substances (NPS).

Health Risks and Toxicity

The health risks associated with MDMB-5Br-INACA are not well-documented, but synthetic cannabinoids, in general, have been linked to severe adverse effects, including psychosis, seizures, and cardiovascular problems. The lack of clinical studies makes it difficult to fully understand the toxicity and long-term effects of this compound.

Detection in Biological Samples

MDMB-5Br-INACA can be detected in biological samples using advanced analytical techniques such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). These methods are essential for forensic and clinical toxicology.

See Also

• Synthetic cannabinoids
• Cannabinoid receptor
• Endocannabinoid system
• New psychoactive substances